Cargando…

Correction of aging phenotype in the liver

Detalles Bibliográficos
Autores principales:	Rodriguez, Katherine, Cast, Ashley, Timchenko, Nikolai A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128412/ https://www.ncbi.nlm.nih.gov/pubmed/30103212 http://dx.doi.org/10.18632/aging.101523

Ejemplares similares

Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver Disease
por: Cast, Ashley, et al.
Publicado: (2019)

Elimination of Age-Associated Hepatic Steatosis and Correction of Aging Phenotype by Inhibition of cdk4-C/EBPα-p300 Axis
por: Nguyen, Phuong, et al.
Publicado: (2018)

GSK3β and aging liver
por: Jin, Jingling, et al.
Publicado: (2009)

PARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastoma
por: Valanejad, Leila, et al.
Publicado: (2018)

Help for Sick Kids: New Insights Into Hepatoblastoma
por: Timchenko, Nikolai A.
Publicado: (2021)

Small Molecule Cjoc42 Improves Chemo-Sensitivity and Increases Levels of Tumor Suppressor Proteins in Hepatoblastoma Cells and in Mice by Inhibiting Oncogene Gankyrin
por: D’Souza, Amber M., et al.
Publicado: (2021)

Molecular signatures of aggressive pediatric liver cancer
por: Johnston, Michael E., et al.
Publicado: (2021)

Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation
por: D’Souza, Amber M., et al.
Publicado: (2018)

Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics
por: Timchenko, Lubov
Publicado: (2022)

Cell-type specific functions of epidermal growth factor receptor are involved in development of hepatocellular carcinoma
por: Timchenko, Nikolai A
Publicado: (2015)

GSK3β is a new therapeutic target for myotonic dystrophy type 1
por: Wei, Christina, et al.
Publicado: (2013)

Physical activity fragmentation as a potential phenotype of accelerated aging
por: Wanigatunga, Amal A., et al.
Publicado: (2019)

Biological age of transplanted livers
por: Capri, Miriam, et al.
Publicado: (2018)

Phenotypic heterogeneity and cooperation in the metastatic cascade
por: Young, Katherine M., et al.
Publicado: (2022)

Clustering NAFLD: phenotypes of nonalcoholic fatty liver disease and their differing trajectories
por: Kantartzis, Konstantinos, et al.
Publicado: (2023)

Epigenetics of the blood pressure reactivity to salt: Is the salt sensitive phenotype correctable?
por: Cubeddu, Luigi X
Publicado: (2023)

β‐catenin cancer–enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinoma
por: Gulati, Ruhi, et al.
Publicado: (2022)

HDAC1-Dependent Repression of Markers of Hepatocytes and P21 Is Involved in Development of Pediatric Liver Cancer
por: Rivas, Maria, et al.
Publicado: (2021)

Glutamine, fatty liver disease and aging
por: Simón, Jorge, et al.
Publicado: (2021)

Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1
por: Timchenko, Lubov
Publicado: (2019)

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
por: Chun, Ho Soo, et al.
Publicado: (2023)

Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy
por: Lutz, Maggie, et al.
Publicado: (2023)

Mechanisms and Implications of Age-Related Changes in the Liver
por: Cogger, Victoria C., et al.
Publicado: (2011)

GPR109A activation and aging liver
por: Jadeja, Ravirajsinh N., et al.
Publicado: (2019)

CAST Physics Proposal to SPSC
por: CAST, Collaboration
Publicado: (2011)

The Era of Pediatric Liver Transplantation in India
por: D'Cruz, Ashley L. J.
Publicado: (2020)

Enhancing CISD2 expression to retard liver aging
por: Huang, Yi-Long, et al.
Publicado: (2022)

Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver Cancer
por: D’Souza, Amber M., et al.
Publicado: (2022)

Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive Hepatoblastoma
por: Gulati, Ruhi, et al.
Publicado: (2022)

Ghrelin deletion protects against age‐associated hepatic steatosis by downregulating the C/EBPα‐p300/DGAT1 pathway
por: Guillory, Bobby, et al.
Publicado: (2017)

Unraveling Metabolic Dysfunction-Associated Fatty Liver Disease: Refining Sub-Phenotypes for Resolving Its Heterogeneity
por: Park, Jung Gil
Publicado: (2023)

Pediatric liver transplantation in India: Its time has come
por: D'Cruz, Ashley L.J.
Publicado: (2011)

It’s Ready for Targeting Muscle in Nonalcoholic Fatty Liver in This Era of Aging
por: Joo, Sae Kyung, et al.
Publicado: (2019)

CAST - Status Report to the SPSC for the 127th Meeting and Planning for 2018
por: Fischer, H, et al.
Publicado: (2017)

Can Diagnostic Specificity and Phenotyping Aid in Evaluating Cardiometabolic Risk of Maternal Sleep-disordered Breathing?
por: Sharkey, Katherine M., et al.
Publicado: (2022)

Effects of aging on liver microcirculatory function and sinusoidal phenotype
por: Maeso‐Díaz, Raquel, et al.
Publicado: (2018)

Hepatic Macrophage Abundance and Phenotype in Aging and Liver Iron Accumulation
por: Bloomer, Steven A.
Publicado: (2022)

Viruses and the Liver 2020: Before COVID-19 and the beginning of a new age in medicine
por: Panduro, Arturo
Publicado: (2021)

Phenotypes of Klotho
por: Sen, Jyoti Misra
Publicado: (2019)

Sarcoidosis Phenotypes
por: Francesqui, Joel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3pkcqhts2ei3qn82qr21d93t9h